EVALAR JSC Decision Maker Intelligence

EVALAR JSC is a in the Pharmaceuticals industry. It researches, develops, and delivers medicinal products — covering prescription drugs, OTC medicines, biologics, and specialty therapeutics. The company serves healthcare providers, hospital networks, retail pharmacies, and regulated distribution channels.

EVALAR JSC has been operating since 1991. That experience reflects well-established R&D capabilities, deeper regulatory knowledge, and long-standing relationships with clinical partners and approved suppliers.

EVALAR JSC is headquartered in Russia. Operating location determines regulatory jurisdiction — US-based companies follow FDA frameworks, while others operate under EMA, WHO, or local health authority requirements.

EVALAR JSC operates as a . Innovator companies develop and patent new drug compounds; generic manufacturers produce off-patent formulations; distributors supply products to pharmacy, hospital, and clinical channels. EVALAR JSC may operate across more than one of these roles.

EVALAR JSC is led by Violetta Kazakova, External Communications Manager. Leadership in pharmaceuticals typically comes from clinical research, regulatory affairs, medicinal chemistry, or commercial strategy — backgrounds that directly influence pipeline decisions and market positioning.

Violetta Kazakova serves as External Communications Manager at EVALAR JSC, responsible for drug development pipelines, regulatory submissions, quality assurance, and commercial growth across prescription and OTC channels.